Advanced search
Publication Cover
Neuropsychiatric Disease and Treatment Volume 5, 2009 - Issue
Submit an article Journal homepage
93
Views
6
CrossRef citations to date
0
Altmetric
Original Research

Safety and tolerability of flexible dosages of prolonged-release OROS methylphenidate in adults with attention-deficit/hyperactivity disorder

Jan K Buitelaar1 Department of Psychiatry, University Medical Center, St. Radboud and Karakter Child and Adolescent Psychiatry University Center, Nijmegen, The NetherlandsCorrespondence[email protected]
,
J Antoni Ramos-Quiroga2 Department of Psychiatry, Hospital Universitari Vall d’Hebron and Department of Psychiatry and Legal Medicine, Universitat Autònoma de Barcelona, Barcelona, Spain
,
Miguel Casas2 Department of Psychiatry, Hospital Universitari Vall d’Hebron and Department of Psychiatry and Legal Medicine, Universitat Autònoma de Barcelona, Barcelona, Spain
,
J J Sandra Kooij3 PsyQ, Psycho-Medical Programs, Program Adult ADHD, Den Haag, The Netherlands
,
Asko Niemelä4 Oulu University Hospital, Department of Psychiatry, Oulu, Finland
,
Eric Konofal5 Groupe Hospitalier Pitie-Salpetriere, Paris, France
,
Joachim Dejonckheere6 SGS Life Sciences, Mechelen, Belgium
,
Bradford H Challis7 Johnson & Johnson Pharmaceutical Research and Development, Titusville, NJ, USA
&
Rossella Medori8 Janssen-Cilag EMEA, Neuss, Germany
 show all
Pages 457-466 | Published online: 24 Aug 2009

Citations (6)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (5)

Michael Huss, Praveen Duhan, Preetam Gandhi, Chien-Wei Chen, Carsten Spannhuth & Vinod Kumar. (2017) Methylphenidate dose optimization for ADHD treatment: review of safety, efficacy, and clinical necessity. Neuropsychiatric Disease and Treatment 13, pages 1741-1751.
Read now
Annabeth P. Groenman, Lizanne J.S. Schweren, Andrea Dietrich & Pieter J. Hoekstra. (2017) An update on the safety of psychostimulants for the treatment of attention-deficit/hyperactivity disorder. Expert Opinion on Drug Safety 16:4, pages 455-464.
Read now
Doris Susanne Konrad-Bindl, Ursula Gresser & Barbara Maria Richartz. (2016) Changes in behavior as side effects in methylphenidate treatment: review of the literature. Neuropsychiatric Disease and Treatment 12, pages 2635-2647.
Read now
Nagahide Takahashi, Tadaishi Koh, Yushin Tominaga, Yuki Saito, Yuji Kashimoto & Taka Matsumura. (2014) A randomized, double-blind, placebo-controlled, parallel-group study to evaluate the efficacy and safety of osmotic-controlled release oral delivery system methylphenidate HCl in adults with attention-deficit/hyperactivity disorder in Japan. The World Journal of Biological Psychiatry 15:6, pages 488-498.
Read now
Miguel Casas, Michael Rösler, J. J. Sandra Kooij, Ylva Ginsberg, Josep Antoni Ramos-Quiroga, Steffen Heger, Joris Berwaerts, Joachim Dejonckheere, Erik van der Vorst & Barbara Schäuble. (2013) Efficacy and safety of prolonged-release OROS methylphenidate in adults with attention deficit/hyperactivity disorder: A 13-week, randomized, double-blind, placebo-controlled, fixed-dose study. The World Journal of Biological Psychiatry 14:4, pages 268-281.
Read now

Articles from other publishers (1)

Kim Boesen, Asger Sand Paludan-Müller, Peter C Gøtzsche & Karsten Juhl Jørgensen. (2022) Extended-release methylphenidate for attention deficit hyperactivity disorder (ADHD) in adults. Cochrane Database of Systematic Reviews 2022:2.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.